BACKGROUND: Chlorhexidine showering is frequently recommended as an important preoperative measure to prevent surgical site infection (SSI). However, the efficacy of this approach is uncertain. METHODS: A search of electronic databases was undertaken to identify prospective controlled trials evaluating whole-body preoperative bathing with chlorhexidine versus placebo or no bath for prevention of SSI. Summary risk ratios were calculated using a DerSimonian-Laird random effects model and a Mantel-Haenzel dichotomous effects model. RESULTS: Sixteen trials met inclusion criteria with a total of 17,932 patients: 7,952 patients received a chlorhexidine bath, and 9,980 patients were allocated to various comparator groups. Overall, 6.8% of patients developed SSI in the chlorhexidine group compared with 7.2% of patients in the comparator groups. Chlorhexidine bathing did not significantly reduce overall incidence of SSI when compared with soap, placebo, or no shower or bath (relative risk, 0.90; 95% confidence interval: 0.77-1.05, P = .19). CONCLUSIONS: Meta-analysis of available clinical trials suggests no appreciable benefit of preoperative whole-body chlorhexidine bathing for prevention of SSI. However, most studies omitted details of chlorhexidine application. Better designed trials with a specified duration and frequency of exposure to chlorhexidine are needed to determine whether preoperative whole-body chlorhexidine bathing reduces SSI.
BACKGROUND:Chlorhexidine showering is frequently recommended as an important preoperative measure to prevent surgical site infection (SSI). However, the efficacy of this approach is uncertain. METHODS: A search of electronic databases was undertaken to identify prospective controlled trials evaluating whole-body preoperative bathing with chlorhexidine versus placebo or no bath for prevention of SSI. Summary risk ratios were calculated using a DerSimonian-Laird random effects model and a Mantel-Haenzel dichotomous effects model. RESULTS: Sixteen trials met inclusion criteria with a total of 17,932 patients: 7,952 patients received a chlorhexidine bath, and 9,980 patients were allocated to various comparator groups. Overall, 6.8% of patients developed SSI in the chlorhexidine group compared with 7.2% of patients in the comparator groups. Chlorhexidine bathing did not significantly reduce overall incidence of SSI when compared with soap, placebo, or no shower or bath (relative risk, 0.90; 95% confidence interval: 0.77-1.05, P = .19). CONCLUSIONS: Meta-analysis of available clinical trials suggests no appreciable benefit of preoperative whole-body chlorhexidine bathing for prevention of SSI. However, most studies omitted details of chlorhexidine application. Better designed trials with a specified duration and frequency of exposure to chlorhexidine are needed to determine whether preoperative whole-body chlorhexidine bathing reduces SSI.
Authors: Karthik C Bassetty; Dhanya Susan Thomas; Ajit Sebastian; Anitha Thomas; Rachel Chandy; Abraham Peedicayil; Vinotha Thomas Journal: J Obstet Gynaecol India Date: 2021-07-01
Authors: Susan E Kline; Erinn C Sanstead; James R Johnson; Shalini L Kulasingam Journal: Infect Control Hosp Epidemiol Date: 2018-09-20 Impact factor: 3.254
Authors: Melvin Chugh Makhni; Kolawole Jegede; Joseph Lombardi; Susan Whittier; Prakash Gorroochurn; Ronald A Lehman; K Daniel Riew Journal: J Am Acad Orthop Surg Date: 2018-01-15 Impact factor: 3.020
Authors: Simon G Ammanuel; Caleb S Edwards; Andrew K Chan; Praveen V Mummaneni; Joseph Kidane; Enrique Vargas; Sarah D'Souza; Amy D Nichols; Sujatha Sankaran; Adib A Abla; Manish K Aghi; Edward F Chang; Shawn L Hervey-Jumper; Sandeep Kunwar; Paul S Larson; Michael T Lawton; Philip A Starr; Philip V Theodosopoulos; Mitchel S Berger; Michael W McDermott Journal: J Neurosurg Date: 2021-04-30 Impact factor: 5.408